At the completion of this activity, the participant will be able to:

  1. Examine the current landscape of anticoagulation with vitamin K antagonists, direct thrombin inhibitors, and factor Xa inhibitors
  2. Discuss the role of factor XI and its emergence as a potential therapeutic target
  3. Analyze recently published literature regarding factor XI inhibitors being developed
  4. Apply therapeutic considerations to select patient cases involving factor XI inhibitors
Session date: 
10/20/2025 - 12:00pm to 1:00pm EDT
Location: 
AGH Board Room (1st Floor South Tower; Magovern Conference Area)
To Join the Zoom Webinar: https://highmarkhealth.zoom.us/j/98672570454?pwd=VU80YWJYNjgraGVsQ0xkU2xSNWozQT09
Meeting ID: 986 7257 0454; Passcode: 877628
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Please login or register to take this course.